Daiss, J., Carney, J., Cartun, R., Codington, J., Erdrich, C., Hinchman, C., … Schnipelsky, P. (2003). Human Carcinoma Antigen: A Marker Useful for Discriminating between Benign Prostatic Hyperplasia and Prostate Cancer. Journal of Clinical Ligand Assay, 26, 177–180.

Daiss, J., J. Carney, R. Cartun, J. Codington, C. Erdrich, C. Hinchman, J. Huang, J. Mauck, and P. Schnipelsky. “Human Carcinoma Antigen: A Marker Useful for Discriminating between Benign Prostatic Hyperplasia and Prostate Cancer.” Journal of Clinical Ligand Assay 26 (2003): 177–80.

Daiss J, Carney J, Cartun R, Codington J, Erdrich C, Hinchman C, et al. Human Carcinoma Antigen: A Marker Useful for Discriminating between Benign Prostatic Hyperplasia and Prostate Cancer. Journal of Clinical Ligand Assay. 2003;26:177–80.

Daiss, J., et al. “Human Carcinoma Antigen: A Marker Useful for Discriminating between Benign Prostatic Hyperplasia and Prostate Cancer.” Journal of Clinical Ligand Assay, vol. 26, European Ligand Assay Society, 2003, pp. 177–80.

Daiss J, Carney J, Cartun R, Codington J, Erdrich C, Hinchman C, Huang J, Mauck J, Schnipelsky P. Human Carcinoma Antigen: A Marker Useful for Discriminating between Benign Prostatic Hyperplasia and Prostate Cancer. Journal of Clinical Ligand Assay. European Ligand Assay Society; 2003;26:177–180.